Mar 16, 2020 11:00am EDT XORTX Launches XRx-101 Following the Filing of a Provisional Patent to Potentially Treat Respiratory and Kidney Disease Injury Due to Coronavirus Infection
Mar 16, 2020 7:00am EDT XORTX Launches XRx-101, A New Program to Treat Coronavirus COVID-19 Infection
Sep 19, 2019 9:00pm EDT XORTX Announces Positive Phase 2 Results in Type 2 Diabetic Nephropathy (T2DN)
Apr 29, 2019 5:09pm EDT XORTX Provides Overview and Announces $5 Million Financing to Advance Clinical Trials
Apr 16, 2019 10:55am EDT XORTX Shares Findings of Diabetes Study in Youths Supporting High Uric Acid Advances Kidney Disease Progression